Additional simulation outputs that align with commonly-measured NASH biomarkers include the relative amount of liver fat (consistent with MRI-PDFF measurements), body weight, BMI, plasma ALT, plasma AST, and plasma triglycerides. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.